Overview
Ocular coloboma is a developmental eye defect characterized by a gap or notch in one or more structures of the eye, resulting from incomplete closure of the embryonic optic fissure (also called the choroidal fissure) during early fetal development, typically around the fifth to seventh week of gestation. The condition can affect various ocular structures including the iris, ciliary body, zonules, retina, choroid, optic nerve, and/or eyelid. When the iris is involved, the pupil may have a characteristic keyhole or cat-eye appearance. Coloboma can be unilateral or bilateral and varies widely in severity — from a small iris notch with minimal visual impact to extensive chorioretinal or optic nerve colobomas that can cause significant visual impairment or even blindness. Microphthalmia (abnormally small eye) may also be associated. Ocular coloboma can occur as an isolated finding or as part of a broader genetic syndrome, such as CHARGE syndrome, cat-eye syndrome, Treacher Collins syndrome, or other chromosomal and single-gene disorders. The etiology is heterogeneous, involving mutations in genes such as PAX2, SHH, CHD7, MAF, GDF6, and others, as well as chromosomal abnormalities. Both genetic and environmental factors may contribute. Inheritance patterns vary depending on the underlying cause and may include autosomal dominant, autosomal recessive, or X-linked transmission, though many cases are sporadic. Note: This Orphanet entry (ORPHA:194) is marked as OBSOLETE, meaning it may have been reclassified, merged, or replaced by more specific disease entries within the Orphanet classification system. Patients and clinicians should refer to updated Orphanet entries for specific subtypes of coloboma or associated syndromes. There is no cure for ocular coloboma. Management focuses on regular ophthalmologic monitoring, correction of refractive errors, treatment of amblyopia in children, use of cosmetic contact lenses for iris colobomas, and surgical intervention in cases complicated by retinal detachment. Low-vision aids and educational support may be necessary for individuals with significant visual impairment.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Ocular coloboma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Ocular coloboma at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Ocular coloboma.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Ocular coloboma.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Ocular coloboma.
Start the conversation →Latest news about OBSOLETE: Ocular coloboma
No recent news articles for OBSOLETE: Ocular coloboma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Ocular coloboma
What is OBSOLETE: Ocular coloboma?
Ocular coloboma is a developmental eye defect characterized by a gap or notch in one or more structures of the eye, resulting from incomplete closure of the embryonic optic fissure (also called the choroidal fissure) during early fetal development, typically around the fifth to seventh week of gestation. The condition can affect various ocular structures including the iris, ciliary body, zonules, retina, choroid, optic nerve, and/or eyelid. When the iris is involved, the pupil may have a characteristic keyhole or cat-eye appearance. Coloboma can be unilateral or bilateral and varies widely in
At what age does OBSOLETE: Ocular coloboma typically begin?
Typical onset of OBSOLETE: Ocular coloboma is neonatal. Age of onset can vary across affected individuals.